Endoscopic operations in invasive cancer of the urinary bladder


Cite item

Full Text

Abstract

Long-term results of conservative treatment of 153 patients with invasive cancer of the urinary bladder were studied retrospectively. The patients had stage T2 (n = 121, 79.1%), T3 (n = 26, 17%), T4 (n = 6, 3.9%). All the patients had transitional cell cancer. Gl, G2 and G3 tumors were registered in 104(68%), 35(24%) and 12(8%) cases, respectively. 88 (57.5%) patients received combined treatment, 65(42.5%) patients - only surgery. In the patients with a small invasive tumor of the urinary bladder subjected to surgery alone (TUR-vaporization), overall 5-year survival was 70.4%. In patients with advanced cancer of the urinary bladder who had received curative radiotherapy in case of superficial residual tumor had TUR-vaporization of the urinary bladder overall 5-year survival was 76.5%. In patients exposed to large-fraction (TFD 20-25 Gy) preoperative radiotherapy followed by TUR-vaporization, survival at this moment was 84.6%. Three-year overall and recurrence-free survival at stage T2 was 97.5 and 47.4%, respectively; at stage T3 and T4 overall 3-year survival was 57.1 and 26.6%, respectively. Thus, the conclusion is that transurethral electrosurgery in conservative therapy of patients with invasive cancer of the urinary bladder is a promising approach.

References

  1. Яненко Э. К., Кульга Л. Г., Поповкин Н. Н. и др. Распространенность рака мочевого пузыря в России и разработка методов его профилактики и лечения. В кн.: Рак мочевого пузыря: Материалы Всероссийской науч. конф. Ростов-н/ Д.; 1998. 106-107.
  2. Чиссов В. И., Старинский. Состояние онкологической помощи населению России в 2000 г. В кн.: Сборник МНИОИ им. Герцена П. А. М.; 2001. 191.
  3. Матвеев Б. П., Фигурин К. М., Корякин О. Б. Рак мочевого пузыря. М.: Вердана; 2001.
  4. Переверзев А. С. Можно ли оспаривать возможность органосохраняющих операций при раке мочевого пузыря. В кн.: Актуальные вопросы лечения онкоурологических заболеваний: Материалы 4-й Всероссийской конф. с участием стран СНГ. М.; 2001. 73-74.
  5. Попов А. М., Корякин О. Б. Органосохраняющее лечение инвазивного рака мочевого пузыря.
  6. Thunnan S. A., DeWeese T. L. Multimodality therapy for the treatment of muscle-invasive bladder cancer. Semin. Urol. Oncol. 2000; 18 (4): 313-322.
  7. Zietman A. L., Shipley W. U., Kaufman D. S. Organ-conserving approaches to muscle-invasive bladder cancer: future alternatives to radical cystectomy. Ann. Med. 2000; 32 (1): 34-42.
  8. Juffs H. G., Moore M. J., Tannock I. F. The role of systemic chemotherapy in the management of muscle-invasive bladder cancer. Lancet Oncol. 2002. 3(12): 738-742.
  9. Kim H. L., Steinberg G. D. The current status of bladder preservation in the treatment of muscle invasive bladder cancer. J. Urol. (Baltimore) 2000; 164 (3, pt 1): 627-632.
  10. Лопаткин Н. А. Оперативное лечение опухолей мочевого пузыря. В кн.: Материалы пленума Всероссийского о-ва урологов. Кемерово; 1995. 157-174.
  11. Sweeney P., Kursh E. D., Resnick M. I. Partial cystectomy. Urol. Clin. North Am. 1992; 19: 10701-10711.
  12. Barnes R. W., Dick A. L., Handley H. L. et al. Survival following transurethral resection bladder carcinoma. Cancer Res. 1977; 37: 2895-2898.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2005 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies